526.5500 1.20 (0.23%)
NSE May 11, 2026 15:31 PM
Volume: 97,350
 

Axis Direct
We expect Gross Margins to be impacted due to an increase in revenue share from non-regulated markets and an increase in raw material prices going onwards. Hence, we recommend a HOLD rating on the stock with a target price of INR 1,670 (PE 20x for FY23EPS).
Solara Active Pharma Sciences Ltd. is trading above its 100 day SMA of 504.2
More from Solara Active Pharma Sciences Ltd.
Recommended